Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Br J Haematol ; 194(3): 537-541, 2021 08.
Artigo em Inglês | MEDLINE | ID: mdl-33991422

RESUMO

Infections are one of the well-known precipitating factors for relapses in patients with immune thrombocytopenia (ITP). Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection can sometimes lead to or be associated with thrombocytopenia due to an increase in peripheral platelet destruction from inflammatory hyperactivation. Currently, we do not know if SARS-CoV-2 infection modifies the natural evolution of chronic or persistent ITP or if previous immunosuppression of patients with ITP influences the incidence and severity of coronavirus disease 2019 (COVID-19) in this group. The present study was an observational, multicentre, national series of 32 adult patients with pre-existing ITP and subsequent SARS-CoV-2 infection, collected by the Spanish ITP Group [Grupo Español de Trombocitopenia Inmune (GEPTI)].


Assuntos
COVID-19/epidemiologia , Púrpura Trombocitopênica Idiopática/complicações , Adulto , Idoso , Idoso de 80 Anos ou mais , COVID-19/diagnóstico , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , SARS-CoV-2/isolamento & purificação , Espanha/epidemiologia
2.
Enferm. clín. (Ed. impr.) ; 24(3): 200-204, mayo.-jun. 2014. ilus, tab
Artigo em Espanhol | IBECS | ID: ibc-124490

RESUMO

En la actualidad, en nuestro país, alrededor de un millón de personas reciben anticoagulación oral. El fármaco más empleado es el acenocumarol, que requiere de controles de coagulación para constatar que el paciente se encuentra dentro de su rango terapéutico. Los pacientes suelen empezar este tratamiento en una consulta hospitalaria y, cuando se encuentran estabilizados, son derivados a atención primaria, donde son seguidos por sus enfermeras comunitarias.La práctica habitual es que estas enfermeras asuman los cambios de dosis cuando los pacientes están fuera de rango; no obstante, este aspecto no es realizado por las enfermeras hospitalarias a pesar de disponer de suficiente experiencia y conocimientos para un adecuado manejo de este tipo de pacientes.En la Unidad de Gestión Clínica de Hematología del Hospital Universitario Virgen de la Victoria de Málaga se ha implantado un modelo de Enfermería de Práctica Avanzada que incluye diversos aspectos de la atención y cuidados a los pacientes en terapia antitrombótica, entre los que se encuentra la dosificación de su tratamiento siguiendo un catálogo de rangos terapéuticos y diagnósticos


There is currently around one million people receiving oral anticoagulants in Spain. The drug most used is acenocoumarol, which requires coagulation monitoring to ensure that the patient is within its normal therapeutic range. Patients usually start this treatment in a hospital clinic and, when they are stabilised, they are referred to primary care, where they are followed-up by their community nurses. The usual practice is that nurses are responsible for changes in the dose when the patients are outside the range. This practice is not performed by hospital nurses, despite having sufficient experience and knowledge to adequately manage these types of patients. An Advanced Nursing Practice model has been introduced into the Haematology management unit of the Hospital Universitario Virgen de la Victoria, Málaga. This involves various aspects of attention and care of patients on anticoagulant therapy, and includes adjusting the doses of their treatment following a catalogue of therapeutic and diagnostic ranges


Assuntos
Humanos , Prática Avançada de Enfermagem/organização & administração , Fibrinolíticos/uso terapêutico , Terapia Trombolítica/enfermagem , Anticoagulantes/uso terapêutico , Conduta do Tratamento Medicamentoso/organização & administração , Cuidados de Enfermagem/organização & administração , Trombose/prevenção & controle
3.
Enferm Clin ; 24(3): 200-4, 2014.
Artigo em Espanhol | MEDLINE | ID: mdl-24746343

RESUMO

There is currently around one million people receiving oral anticoagulants in Spain. The drug most used is acenocoumarol, which requires coagulation monitoring to ensure that the patient is within its normal therapeutic range. Patients usually start this treatment in a hospital clinic and, when they are stabilised, they are referred to primary care, where they are followed-up by their community nurses. The usual practice is that nurses are responsible for changes in the dose when the patients are outside the range. This practice is not performed by hospital nurses, despite having sufficient experience and knowledge to adequately manage these types of patients. An Advanced Nursing Practice model has been introduced into the Haematology management unit of the Hospital Universitario Virgen de la Victoria, Málaga. This involves various aspects of attention and care of patients on anticoagulant therapy, and includes adjusting the doses of their treatment following a catalogue of therapeutic and diagnostic ranges.


Assuntos
Prática Avançada de Enfermagem , Anticoagulantes/uso terapêutico , Trombose/prevenção & controle , Instituições de Assistência Ambulatorial , Enfermagem em Saúde Comunitária , Humanos , Coeficiente Internacional Normatizado , Processo de Enfermagem , Registros , Espanha
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...